Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).
about
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses.Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.The economic burden of human papillomavirus-related precancers and cancers in Sweden.Viral load, integration and methylation of E2BS3 and 4 in human papilloma virus (HPV) 16-positive vaginal and vulvar carcinomas.Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control studyThe DNA load of six high-risk human papillomavirus types and its association with cervical lesions.Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.Genomic instability of the host cell induced by the human papillomavirus replication machineryEarly integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histologyHuman papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.Association of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region.Molecular profiling of cervical neoplasia.Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer.Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR.Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV typesDetection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3.Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology.Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions.Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women.Consolidation of molecular testing in clinical virology.Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.Molecular approaches for HPV genotyping and HPV-DNA physical status.Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study.Immunohistochemistry and real-time PCR as diagnostic tools for detection of Borrelia burgdorferi sensu lato in ticks collected from humans.Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva.Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece.Correlation between physical status of human papilloma virus and cervical carcinogenesis.Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.
P2860
Q33434433-B9308C97-571D-4347-A5BA-CFE39164883AQ33798276-40ED29F6-9F60-42A3-B650-8AC4F31C5E6AQ33833645-4C9CFC7B-8608-411B-8BF0-0D22C8C483ACQ33834660-E784AEED-4C9D-4384-8689-F7A48CA18F40Q34506898-84ED7580-2510-4E03-8882-664891579820Q34834113-B2A5E891-A5A4-4156-9652-55590865E101Q35164587-67384158-69CD-4F16-B3EB-7F24147965B7Q35405533-293DB6EC-0D6F-48DF-A6BF-AE66FD557CFFQ35752761-ED03244D-9261-47C5-9958-ACEB48618195Q35769572-DD78E071-BD45-40FC-B980-D0E8C8ACB48EQ35821601-5F37935B-57D4-4E69-A697-1D6F7F4369C5Q36012702-857E2EEA-75E8-41E7-AC59-7D55DE07C955Q36174016-C986A4B1-6F0E-4E2F-AC0C-B9BFA517931CQ36289493-B30B4B42-0D48-4FFA-BBE1-E6C3D2444A95Q36411685-4EDFA797-FC6F-465F-ACA0-BB0414E44B5FQ36423738-B2534BB9-CC0D-411C-8A3A-8C23DE70273BQ36514349-2CD9C959-7C47-4BFA-800B-8ED4E433C08DQ36539864-9FC5FB1B-2D67-48B8-806E-8FBA9B8FCF0CQ36957989-179599C3-E83A-4D2C-93CC-FBAC2876C710Q36982644-A4243C5E-A9C9-4941-99D5-CBC8CE016C46Q37099537-B8CE0650-799F-488C-A736-BC15334843B1Q37116735-5848244D-F3D5-41CB-8C99-6A6B49FAF45FQ37295681-FFDEEE59-CDC2-4AEE-A3BB-6E163FE9BD45Q37406155-57AE0CED-FB49-410A-BC7B-FBBE76D68329Q37443985-7407C817-D01F-43C7-B26E-5BF97C205689Q37487505-AA299C8B-21EC-4919-A82D-7A8274811E66Q37516391-4CEC4CE5-C5B6-4D8D-A44C-2D09D1FBDD21Q37579625-ED73FB6A-3518-4AE6-BF50-681B941F537FQ38779627-A059409A-6C90-4134-8281-78C4F49193EEQ39040989-BAD6E816-3C3F-48AC-AF3D-3C51205573F4Q39120200-9012A584-03E0-4136-962D-F6E79F929D93Q40597956-E412868F-1756-4C42-9D26-C57DBF5AEEDBQ40821346-A18CCADB-DCAD-4C51-A445-01F643FE8562Q44634016-5B4D9AA5-2A50-4817-A1E4-8B8DD7E78384Q45360017-84DACABB-BEE1-48B1-AC64-E904E2B8C561Q45360122-D316F359-873B-4372-A7FE-53C712F5228FQ47599029-4602BCD5-EC94-411F-92F2-8B3F7A4FA2CEQ54218651-C2D9997D-7972-45EF-AAEC-885DF7C3D101Q54565226-4AD5705A-D038-4D28-A760-8785918AC316
P2860
Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Type distribution, viral load ...... ages of cervical cancer (CIN).
@ast
Type distribution, viral load ...... ages of cervical cancer (CIN).
@en
type
label
Type distribution, viral load ...... ages of cervical cancer (CIN).
@ast
Type distribution, viral load ...... ages of cervical cancer (CIN).
@en
prefLabel
Type distribution, viral load ...... ages of cervical cancer (CIN).
@ast
Type distribution, viral load ...... ages of cervical cancer (CIN).
@en
P2093
P2860
P356
P1476
Type distribution, viral load ...... ages of cervical cancer (CIN).
@en
P2093
B Johansson
I Lewensohn-Fuchs
S Andersson
U Gyllensten
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602648
P407
P577
2005-06-01T00:00:00Z